Antibiotic resistance continues to push modern medicine into dangerous territory. In hospitals around the world, infections ...
Alert EMA Backs First Drug for Severe Overgrowth Disorders The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening PIK3CA-related overgrowth ...
Alert FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results